487 related articles for article (PubMed ID: 25727105)
1. Diameter-dependent release of a cisplatin pro-drug from small and large functionalized carbon nanotubes.
Muzi L; Ménard-Moyon C; Russier J; Li J; Chin CF; Ang WH; Pastorin G; Risuleo G; Bianco A
Nanoscale; 2015 Mar; 7(12):5383-94. PubMed ID: 25727105
[TBL] [Abstract][Full Text] [Related]
2. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
3. In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes.
Li J; Pant A; Chin CF; Ang WH; Ménard-Moyon C; Nayak TR; Gibson D; Ramaprabhu S; Panczyk T; Bianco A; Pastorin G
Nanomedicine; 2014 Oct; 10(7):1465-75. PubMed ID: 24486857
[TBL] [Abstract][Full Text] [Related]
4. Carbon nanotubes buckypapers for potential transdermal drug delivery.
Schwengber A; Prado HJ; Zilli DA; Bonelli PR; Cukierman AL
Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():7-13. PubMed ID: 26354234
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin.
Yoong SL; Wong BS; Zhou QL; Chin CF; Li J; Venkatesan T; Ho HK; Yu V; Ang WH; Pastorin G
Biomaterials; 2014 Jan; 35(2):748-59. PubMed ID: 24140044
[TBL] [Abstract][Full Text] [Related]
6. Functionalized Multiwalled Carbon Nanotubes as Carriers of Ruthenium Complexes to Antagonize Cancer Multidrug Resistance and Radioresistance.
Wang N; Feng Y; Zeng L; Zhao Z; Chen T
ACS Appl Mater Interfaces; 2015 Jul; 7(27):14933-45. PubMed ID: 26107995
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile.
Sui L; Yang T; Gao P; Meng A; Wang P; Wu Z; Wang J
Int J Pharm; 2014 Aug; 471(1-2):157-65. PubMed ID: 24853461
[TBL] [Abstract][Full Text] [Related]
8. Carbon nanotube capsules enhance the in vivo efficacy of cisplatin.
Guven A; Villares GJ; Hilsenbeck SG; Lewis A; Landua JD; Dobrolecki LE; Wilson LJ; Lewis MT
Acta Biomater; 2017 Aug; 58():466-478. PubMed ID: 28465075
[TBL] [Abstract][Full Text] [Related]
9. Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death.
Arlt M; Haase D; Hampel S; Oswald S; Bachmatiuk A; Klingeler R; Schulze R; Ritschel M; Leonhardt A; Fuessel S; Büchner B; Kraemer K; Wirth MP
Nanotechnology; 2010 Aug; 21(33):335101. PubMed ID: 20657048
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-functionalised single-walled carbon nanotube-mediated drug delivery of SNX-2112 in cancer cells.
Zheng L; Wu S; Tan L; Tan H; Yu B
J Biomater Appl; 2016 Sep; 31(3):379-86. PubMed ID: 27231263
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery.
Guven A; Rusakova IA; Lewis MT; Wilson LJ
Biomaterials; 2012 Feb; 33(5):1455-61. PubMed ID: 22078812
[TBL] [Abstract][Full Text] [Related]
12. Polyamidoamine dendrimer-functionalized carbon nanotubes-mediated GFP gene transfection for HeLa cells: effects of different types of carbon nanotubes.
Yang K; Qin W; Tang H; Tan L; Xie Q; Ma M; Zhang Y; Yao S
J Biomed Mater Res A; 2011 Nov; 99(2):231-9. PubMed ID: 21976448
[TBL] [Abstract][Full Text] [Related]
13. Enhance the efficiency of 5-fluorouracil targeted delivery by using a prodrug approach as a novel strategy for prolonged circulation time and improved permeation.
Pasban S; Raissi H; Pakdel M; Farzad F
Int J Pharm; 2019 Sep; 568():118491. PubMed ID: 31276765
[TBL] [Abstract][Full Text] [Related]
14. Carbon materials as new nanovehicles in hot-melt drug deposition.
Bielicka A; Wiśniewski M; Terzyk AP; Gauden PA; Furmaniak S; Roszek K; Kowalczyk P; Bieniek A
J Phys Condens Matter; 2013 Sep; 25(35):355002. PubMed ID: 23860420
[TBL] [Abstract][Full Text] [Related]
15. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
[TBL] [Abstract][Full Text] [Related]
16. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors.
Singh R; Pantarotto D; McCarthy D; Chaloin O; Hoebeke J; Partidos CD; Briand JP; Prato M; Bianco A; Kostarelos K
J Am Chem Soc; 2005 Mar; 127(12):4388-96. PubMed ID: 15783221
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation into carbon nanotubes and release of anticancer Cisplatin drug molecule.
Mejri A; Vardanega D; Tangour B; Gharbi T; Picaud F
J Phys Chem B; 2015 Jan; 119(2):604-11. PubMed ID: 25514358
[TBL] [Abstract][Full Text] [Related]
18. Magnetic carbon nanotubes with particle-free surfaces and high drug loading capacity.
Vermisoglou EC; Pilatos G; Romanos GE; Devlin E; Kanellopoulos NK; Karanikolos GN
Nanotechnology; 2011 Sep; 22(35):355602. PubMed ID: 21817779
[TBL] [Abstract][Full Text] [Related]
19. Carbon nanofibers and carbon nanotubes sensitize prostate and bladder cancer cells to platinum-based chemotherapeutics.
Ringel J; Erdmann K; Hampel S; Kraemer K; Maier D; Arlt M; Kunze D; Wirth MP; Fuessel S
J Biomed Nanotechnol; 2014 Mar; 10(3):463-77. PubMed ID: 24730242
[TBL] [Abstract][Full Text] [Related]
20. Carbon nanotubes for stabilization of nanostructured lipid particles.
Gaunt NP; Patil-Sen Y; Baker MJ; Kulkarni CV
Nanoscale; 2015 Jan; 7(3):1090-5. PubMed ID: 25475215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
